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OBJECTIVE — Mean blood glucose (MBG) and MBG-independent factors both inﬂuence
A1C levels. Race was related to A1C independent of MBG in adults. The goal of this study was to
determine if racial disparity exists in A1C independent of MBG in children with diabetes.
RESEARCHDESIGNANDMETHODS — Participantsincluded276childrenwithtype
1 diabetes. A1C and MBG were obtained from multiple clinic visits, and a hemoglobin glycation
index (HGI) (an assessment of A1C levels independent of MBG) was calculated. A1C and HGI
were analyzed controlling for age, diabetes duration, and MBG.
RESULTS — AfricanAmericanshadstatisticallysigniﬁcantlyhigherA1C(9.10.1)andHGI
(0.64  0.11) than Caucasians (A1C 8.3  0.1, HGI 0.15  0.07) independent of covariates.
CONCLUSIONS — Because of racial disparity in A1C, which is independent of MBG, we
recommendthatA1CandMBGbeusedtogethertomaketherapeuticdecisionsforchildrenwith
diabetes.
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O
ur group previously demonstrated
that A1C levels are determined by
mean blood glucose (MBG) and
MBG-independent factors (1–3). Identiﬁ-
cation of MBG-independent factors that
inﬂuence A1C levels is important for
proper interpretation of A1C results and
assessmentofglycemiccontrolinpatients
with diabetes, particularly because pa-
tientswithhigherthanaverageA1Clevels
independent of MBG have greater risk of
microvascular complications (2). Recent
data from adults (4–8) indicate that eth-
nicity/race is associated with differences
in A1C independent of MBG. Race may
also be associated with variation in A1C
levelsinchildrenwithorwithoutdiabetes
(9,10), although these ﬁndings were not
shown to be independent of MBG. The
goalofthecurrentstudywastodetermine
if racial disparity exists in A1C indepen-
dent of MBG in children with type 1
diabetes.
RESEARCH DESIGN AND
METHODS— Participants included
276 children from Children’s Hospital of
New Orleans with type 1 diabetes who
self-identiﬁed as either African American
or Caucasian. Patient participation was
approved by the relevant institutional re-
view boards.
MBG and A1C were obtained from
participant medical records between
2002 and 2008, and average values were
calculated for each participant. MBG was
calculated as the mean of self-monitored
blood glucose data downloaded from
strip-based patient glucose meters during
periods of at least 30 days. Most A1C as-
says (98%) were performed at Children’s
Hospital by the DCA 2000 Analyzer
(78%) and later the VITROS 5,1 chemis-
trysystem.Afewsamples(2%)weremea-
sured at outside commercial reference
laboratories. All assays reported results in
National Glycohemoglobin Standardiza-
tion Program (NGSP) equivalents (11).
Statistical analysis indicated no differ-
ences in A1C by assay method.
Evidence for a glucose-independent
effect of race on A1C was tested by using
MBG as a covariate in the analysis, or in a
separate statistical model using the calcu-
lated hemoglobin glycation index (HGI)
described elsewhere in detail (1,2,12).
HGIwascalculatedbysubtractingthepa-
tient’s predicted A1C from the observed
A1C measured at each clinic visit. Pre-
dicted A1C was determined by inserting
the patient’s MBG into a population re-
gression equation {A1C [%]  [MBG
(mg/dl)  0.021]  4.3}. Patients were
dividedintolow,moderate,andhighHGI
groups based on mean HGI tertile (33%)
rankusingpredetermineddelimiters(low
HGI was 0.41, high HGI was 0.26,
and moderate HGI was equal to all values
in between) (12).
Demographic results are presented as
means(1SD).Appropriatetransforma-
tions were applied to variables that were
not normally distributed before ANOVA,
although ﬁndings using raw and trans-
formed data were both statistically signif-
icant and results using raw data are
presented.
RESULTS— Participants included
141 females (51.1%) and 198 Caucasians
(71.7%) with a mean age of 12.5 years
(3.6)andmeandiabetesdurationof4.9
years ( 3.4). The mean number of clinic
visits was 7.7 ( 2.8). Mean A1C was
8.5% ( 1.3), and mean HGI was 0.08
( 1.08).
Participants were classiﬁed into HGI
categories: low HGI (n  89, 32.1%),
moderate HGI (n  94, 33.9%), and
highHGI(n  93,33.7%).Resultsof
2
analyses indicated signiﬁcant differ-
ences in HGI group by race (P  0.001)
but not by sex. Speciﬁcally, 25.6% of
African American children were in the
low HGI group, 16.7% were in the moder-
ate HGI group, and 57.7% were in the high
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34.8% were in the low HGI group, 40.9%
were in the moderate HGI group, and
24.2% were in the high HGI group.
ANOVA was also conducted to eval-
uate differences between African Ameri-
cansandCaucasians.Theanalysisyielded
signiﬁcantly different results for partici-
pant age and MBG, with African Ameri-
cans exhibiting older age (mean 13.2
years for African Americans, 12.2 years
for Caucasians, P  0.05) and higher
MBG (mean 206 mg/dl for African Amer-
icans, 189 mg/dl for Caucasians, P 
0.001) but not longer diabetes duration
(mean 5.1 years for African Americans,
4.8 years for Caucasians, P  0.53).
Results of ANOVA also yielded statis-
tically higher A1C and HGI for African
Americans compared with Caucasians
(Table 1, unadjusted results). ANCOVA
also indicated signiﬁcantly higher A1C
(P  0.001) and HGI (P  0.001) for
AfricanAmericanscomparedwithCauca-
sians, even when controlling for partici-
pant age, diabetes duration, and MBG
(Table 1, adjusted results).
CONCLUSIONS — This study dem-
onstrates that African American children
withdiabeteshavehigherA1Clevelsthan
Caucasians independent of MBG. This
ﬁnding extends similar observations in
adults (7,8) to children with diabetes and
suggests that race was a factor accounting
for between-individual differences in
A1C previously described by our group
(9). Previous analyses suggest that be-
tween-individual differences in A1C in-
dependent of MBG are not due to red
blood cell turnover (1) or artifacts in the
measurement of A1C or calculation of
MBG (12). Biological factors that may in-
ﬂuence intracellular A1C levels indepen-
dent of MBG include those that inﬂuence
nonenzymatic glycation (e.g., pH, glu-
cose transport, and oxidative status) or
enzymatic deglycation (13,14). However,
further research will be necessary to clar-
ify the mechanism of racial disparity in
A1C.
These results indicate that discrepan-
cies exist in the information provided by
MBG versus A1C, particularly for chil-
drenfromdifferentracialgroups,andthat
MBG or A1C alone may not provide com-
plete information about metabolic status.
Because A1C differences independent of
MBG contribute to risk for microvascular
complications (2), this ﬁnding may help
explain why African Americans are at in-
creased risk of diabetes complications
(4,9,15). Given that MBG-independent
disparity in A1C is unlikely to be modiﬁ-
able by glucose-lowering agents, simply
increasing insulin doses to achieve a low-
ered target A1C could lead to greater risk
of hypoglycemia in African American pa-
tients. Evidence of higher A1C levels in
African Americans independent of MBG
also has implications for diagnosis of dia-
betes, whether diagnosis is based on
blood glucose concentration or A1C. We
recommend that both A1C and MBG be
evaluated when making therapeutic deci-
sions in individuals with diabetes, espe-
cially in African Americans, who, based
on current results, exhibit a tendency for
higher A1C levels at any given MBG.
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